Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 13, 2022
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
Edward Tenthoff Maintained (APVO) at Buy with Increased Target to $880 on, May 13th, 2022
Edward Tenthoff of Piper Sandler, Maintained "Aptevo Therapeutics Inc." (APVO) at Buy with Increased Target from $3,036 to $880 on, May 13th, 2022.
Edward, nor any peers, have made any analyst calls on APVO in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30